메뉴 건너뛰기




Volumn 25, Issue 2 SUPPL., 2003, Pages 41-49

Coxibs - Beyond the GI tract: Renal and cardiovascular issues

Author keywords

Cardiovascular; COX 1; COX 2; Cyclooxygenase; Hypertension; Myocardial infarction; Prostacyclin; Renal; Safety; Sodium excretion

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; CAPTOPRIL; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ENALAPRIL; INDOMETACIN; LOSARTAN; NAPROXEN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB;

EID: 0037321487     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0885-3924(02)00630-9     Document Type: Review
Times cited : (47)

References (50)
  • 1
    • 0034707105 scopus 로고    scopus 로고
    • Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
    • Bombardier C., Laine L., Reicin A.et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 343:2000;1520-1528.
    • (2000) N Engl J Med , vol.343 , pp. 1520-1528
    • Bombardier, C.1    Laine, L.2    Reicin, A.3
  • 2
    • 0034644396 scopus 로고    scopus 로고
    • Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: A randomized, controlled trial
    • Silverstein F.E., Faich G., Goldstein J.L.et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study. a randomized, controlled trial JAMA. 284:2000;1247-1255.
    • (2000) JAMA , vol.284 , pp. 1247-1255
    • Silverstein, F.E.1    Faich, G.2    Goldstein, J.L.3
  • 3
    • 0032851480 scopus 로고    scopus 로고
    • A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis
    • Laine L., Harper S., Simon T.et al. A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Gastroenterology. 117:1999;776-783.
    • (1999) Gastroenterology , vol.117 , pp. 776-783
    • Laine, L.1    Harper, S.2    Simon, T.3
  • 4
    • 0033601079 scopus 로고    scopus 로고
    • Adverse upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
    • Langman M.J., Jensen D.M., Watson D.J.et al. Adverse upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. JAMA. 282:1999;1929-1933.
    • (1999) JAMA , vol.282 , pp. 1929-1933
    • Langman, M.J.1    Jensen, D.M.2    Watson, D.J.3
  • 5
    • 0035934070 scopus 로고    scopus 로고
    • Risk of cardiovascular events associated with selective COX-2 inhibitors
    • Mukherjee D., Nissen S.E., Topol E.J. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 286:2001;954-959.
    • (2001) JAMA , vol.286 , pp. 954-959
    • Mukherjee, D.1    Nissen, S.E.2    Topol, E.J.3
  • 6
    • 0021801297 scopus 로고
    • Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function
    • Carmichael J., Shankel S.W. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med. 78:1985;992-1000.
    • (1985) Am J Med , vol.78 , pp. 992-1000
    • Carmichael, J.1    Shankel, S.W.2
  • 7
    • 0025844875 scopus 로고
    • The role of prostaglandins in NSAID-induced renal dysfunction
    • Toto R.D. The role of prostaglandins in NSAID-induced renal dysfunction. J Rheumatol. 28:1991;22-25.
    • (1991) J Rheumatol , vol.28 , pp. 22-25
    • Toto, R.D.1
  • 8
    • 0034702914 scopus 로고    scopus 로고
    • Cyclooxygenase-1 and -2 -dependent prostacyclin formation in patients with atherosclerosis
    • Belton O., Byrne D., Kearney D., Leahy A., Fitzgerald D.J. Cyclooxygenase-1 and -2 -dependent prostacyclin formation in patients with atherosclerosis. Circulation. 102:2000;840-845.
    • (2000) Circulation , vol.102 , pp. 840-845
    • Belton, O.1    Byrne, D.2    Kearney, D.3    Leahy, A.4    Fitzgerald, D.J.5
  • 9
    • 0032867546 scopus 로고    scopus 로고
    • Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly
    • Nantel F., Meadows E., Denis D.et al. Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly. FEBS Lett. 457:1999;475-477.
    • (1999) FEBS Lett , vol.457 , pp. 475-477
    • Nantel, F.1    Meadows, E.2    Denis, D.3
  • 10
    • 0032718593 scopus 로고    scopus 로고
    • The macula densa is worth its salt
    • Schnermann J., Briggs J.P. The macula densa is worth its salt. J Clin Invest. 104:1999;1007-1009.
    • (1999) J Clin Invest , vol.104 , pp. 1007-1009
    • Schnermann, J.1    Briggs, J.P.2
  • 11
    • 0013271607 scopus 로고    scopus 로고
    • Weighing the renal effects of NSAIDs and COX-2 inhibitors
    • Weir M.R., Froch L. Weighing the renal effects of NSAIDs and COX-2 inhibitors. Clinical Dilemmas. 1:2000;3-12.
    • (2000) Clinical Dilemmas , vol.1 , pp. 3-12
    • Weir, M.R.1    Froch, L.2
  • 12
    • 0033428385 scopus 로고    scopus 로고
    • Effects of nonsteroidal anti-inflammatory drugs on renal function: Focus on cyclooxygenase-2-selective inhibition
    • Brater D.C. Effects of nonsteroidal anti-inflammatory drugs on renal function. focus on cyclooxygenase-2-selective inhibition Am J Med. 107(Suppl. 6A):1999;65S-71S.
    • (1999) Am J Med , vol.107 , Issue.SUPPL. 6A
    • Brater, D.C.1
  • 13
    • 0025934766 scopus 로고
    • Nonsteroidal anti-inflammatory drugs: Effects on kidney function
    • Whelton A., Hamilton C.W. Nonsteroidal anti-inflammatory drugs. effects on kidney function J Clin Pharmacol. 31:1991;588-598.
    • (1991) J Clin Pharmacol , vol.31 , pp. 588-598
    • Whelton, A.1    Hamilton, C.W.2
  • 14
    • 0032777567 scopus 로고    scopus 로고
    • Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
    • Rossat J., Maillard M., Nussberger J., Brunner H.R., Burnier M. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther. 66:1999;76-84.
    • (1999) Clin Pharmacol Ther , vol.66 , pp. 76-84
    • Rossat, J.1    Maillard, M.2    Nussberger, J.3    Brunner, H.R.4    Burnier, M.5
  • 15
    • 0034701938 scopus 로고    scopus 로고
    • Effects of celecoxib and naproxen on renal function in the elderly
    • Whelton A., Schulman G., Wallemark C.et al. Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med. 160:2000;1465-1470.
    • (2000) Arch Intern Med , vol.160 , pp. 1465-1470
    • Whelton, A.1    Schulman, G.2    Wallemark, C.3
  • 16
    • 0032948948 scopus 로고    scopus 로고
    • Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids
    • Catella-Lawson F., McAdam B., Morrison B.W.et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther. 289:1999;735-741.
    • (1999) J Pharmacol Exp Ther , vol.289 , pp. 735-741
    • Catella-Lawson, F.1    McAdam, B.2    Morrison, B.W.3
  • 17
    • 0034604272 scopus 로고    scopus 로고
    • Effects of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial
    • Swan S.K., Rudy D.W., Lasseter K.C.et al. Effects of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial. Ann Intern Med. 133:2000;1-9.
    • (2000) Ann Intern Med , vol.133 , pp. 1-9
    • Swan, S.K.1    Rudy, D.W.2    Lasseter, K.C.3
  • 18
    • 0027472279 scopus 로고
    • A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure
    • Pope J.E., Anderson J.J., Felson D.T. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med. 153:1993;477-484.
    • (1993) Arch Intern Med , vol.153 , pp. 477-484
    • Pope, J.E.1    Anderson, J.J.2    Felson, D.T.3
  • 19
    • 0028580588 scopus 로고
    • Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis
    • Johnson A.G., Nguyen T.V., Day R.O. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med. 121:1994;289-300.
    • (1994) Ann Intern Med , vol.121 , pp. 289-300
    • Johnson, A.G.1    Nguyen, T.V.2    Day, R.O.3
  • 20
    • 0027936602 scopus 로고
    • Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy
    • Gurwitz J.H., Avorn J., Bohn R.L.et al. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA. 272:1994;781-786.
    • (1994) JAMA , vol.272 , pp. 781-786
    • Gurwitz, J.H.1    Avorn, J.2    Bohn, R.L.3
  • 21
    • 0027251342 scopus 로고
    • Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population
    • Chrischilles E.A., Wallace R.B. Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population. J Gerontol. 48:1993;91-96.
    • (1993) J Gerontol , vol.48 , pp. 91-96
    • Chrischilles, E.A.1    Wallace, R.B.2
  • 22
    • 0024255773 scopus 로고
    • Propranolol increases prostacyclin synthesis in patients with essential hypertension
    • Beckmann M.L., Gerber J.G., Byyny R.L., Lo-Verde M., Nies A.S. Propranolol increases prostacyclin synthesis in patients with essential hypertension. Hypertension. 12:1988;582-588.
    • (1988) Hypertension , vol.12 , pp. 582-588
    • Beckmann, M.L.1    Gerber, J.G.2    Byyny, R.L.3    Lo-Verde, M.4    Nies, A.S.5
  • 23
    • 1842369627 scopus 로고    scopus 로고
    • Interaction of antihypertensive drugs with anti-inflammatory drugs
    • Polónia J. Interaction of antihypertensive drugs with anti-inflammatory drugs. Cardiology. 88(Suppl. 3):1997;47-51.
    • (1997) Cardiology , vol.88 , Issue.SUPPL. 3 , pp. 47-51
    • Polónia, J.1
  • 24
    • 0029022404 scopus 로고
    • The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil
    • Houston M.C., Weir M., Gray J.et al. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil. Arch Intern Med. 155:1995;1049-1054.
    • (1995) Arch Intern Med , vol.155 , pp. 1049-1054
    • Houston, M.C.1    Weir, M.2    Gray, J.3
  • 25
    • 0029112265 scopus 로고
    • Influence of nonsteroidal anti-inflammatory drugs on renal function and 24-hour ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients
    • Polónia J., Bonaventura I., Gama G.et al. Influence of nonsteroidal anti-inflammatory drugs on renal function and 24-hour ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients. J Hypertens. 13:1995;925-931.
    • (1995) J Hypertens , vol.13 , pp. 925-931
    • Polónia, J.1    Bonaventura, I.2    Gama, G.3
  • 26
    • 0033763236 scopus 로고    scopus 로고
    • Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril
    • Morgan T.O., Anderson A., Bertram D. Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J Hypertens. 13:2000;1161-1167.
    • (2000) Am J Hypertens , vol.13 , pp. 1161-1167
    • Morgan, T.O.1    Anderson, A.2    Bertram, D.3
  • 27
    • 0033817582 scopus 로고    scopus 로고
    • Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients
    • Conlin P.R., Moore T.J., Swartz S.L.et al. Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients. Hypertension. 36:2000;461-465.
    • (2000) Hypertension , vol.36 , pp. 461-465
    • Conlin, P.R.1    Moore, T.J.2    Swartz, S.L.3
  • 28
    • 0000108965 scopus 로고    scopus 로고
    • Celecoxib does not increease the risk of cardiac failure, edema, or hypertension compared to NSAIDs: Results from SUCCESS-1, a double blind, randomized trial in 13,274 OA patients
    • (abstract)
    • Whelton A., Singh G., White W.et al. Celecoxib does not increease the risk of cardiac failure, edema, or hypertension compared to NSAIDs. Results from SUCCESS-1, a double blind, randomized trial in 13,274 OA patients Ann Rheumat Dis. 60(Suppl. 1):2001;237. (abstract).
    • (2001) Ann Rheumat Dis , vol.60 , Issue.SUPPL. 1 , pp. 237
    • Whelton, A.1    Singh, G.2    White, W.3
  • 29
    • 0034041594 scopus 로고    scopus 로고
    • Rofecoxib, a specific inhibitor of cyclooxygenase-2, with clinical efficacy comparable with that of diclofenac sodium
    • Cannon G.W., Caldwell J.R., Holt P.et al. Rofecoxib, a specific inhibitor of cyclooxygenase-2, with clinical efficacy comparable with that of diclofenac sodium. Arthritis Rheum. 43:2000;978-987.
    • (2000) Arthritis Rheum , vol.43 , pp. 978-987
    • Cannon, G.W.1    Caldwell, J.R.2    Holt, P.3
  • 30
    • 0002167244 scopus 로고    scopus 로고
    • Comparative blood pressure effects of rofecoxib, celecoxib and placebo in patients with osteoarthritis (OA): A randomized controlled trial
    • Geba G.P., Polis A.B., Dixon M.E.et al. Comparative blood pressure effects of rofecoxib, celecoxib and placebo in patients with osteoarthritis (OA). a randomized controlled trial Ann Rheum Dis. 60(Suppl. 1):2001;238.
    • (2001) Ann Rheum Dis , vol.60 , Issue.SUPPL. 1 , pp. 238
    • Geba, G.P.1    Polis, A.B.2    Dixon, M.E.3
  • 31
    • 0035286901 scopus 로고    scopus 로고
    • Cyclooxygenase-2-specific inhibitors and cardiorenal function: A randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients
    • Whelton A., Fort J.G., Puma J.A.et al. Cyclooxygenase-2-specific inhibitors and cardiorenal function. a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients Am J Ther. 8:2001;85-95.
    • (2001) Am J Ther , vol.8 , pp. 85-95
    • Whelton, A.1    Fort, J.G.2    Puma, J.A.3
  • 32
    • 0345072560 scopus 로고    scopus 로고
    • Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis: A retrospective cohort study from disease onset
    • Wallberg-Jonsson S., Johansson H., Ohman M.L., Rantapaa-Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. a retrospective cohort study from disease onset J Rheumatol. 26:1999;2562-2571.
    • (1999) J Rheumatol , vol.26 , pp. 2562-2571
    • Wallberg-Jonsson, S.1    Johansson, H.2    Ohman, M.L.3    Rantapaa-Dahlqvist, S.4
  • 33
    • 0028328810 scopus 로고
    • The mortality of rheumatoid arthritis
    • Wolfe F., Mitchell D.M., Sibley J.T.et al. The mortality of rheumatoid arthritis. Arthritis Rheum. 37(4):1994;481-494.
    • (1994) Arthritis Rheum , vol.37 , Issue.4 , pp. 481-494
    • Wolfe, F.1    Mitchell, D.M.2    Sibley, J.T.3
  • 34
    • 0034984730 scopus 로고    scopus 로고
    • C-reactive protein
    • Rosalki S.B. C-reactive protein. Int J Clin Pract. 55(4):2001;269-270.
    • (2001) Int J Clin Pract , vol.55 , Issue.4 , pp. 269-270
    • Rosalki, S.B.1
  • 35
    • 0035187721 scopus 로고    scopus 로고
    • Inflammation and coronary heart disease: An overview
    • Koenig W. Inflammation and coronary heart disease. an overview Cardiol Rev. 9:2001;31-35.
    • (2001) Cardiol Rev , vol.9 , pp. 31-35
    • Koenig, W.1
  • 36
    • 0035799341 scopus 로고    scopus 로고
    • Inflammation and thrombosis: The clot thickens
    • Libby P., Simon D.I. Inflammation and thrombosis. the clot thickens Circulation. 103:2001;1718-1720.
    • (2001) Circulation , vol.103 , pp. 1718-1720
    • Libby, P.1    Simon, D.I.2
  • 37
    • 0033673612 scopus 로고    scopus 로고
    • Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen and naproxen on COX-2 versus COX-1 in healthy volunteers
    • Van Hecken A., Schwartz J.I., Depré M.et al. Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen and naproxen on COX-2 versus COX-1 in healthy volunteers. J Clin Pharmacol. 40:2000;1109-1120.
    • (2000) J Clin Pharmacol , vol.40 , pp. 1109-1120
    • Van Hecken, A.1    Schwartz, J.I.2    Depré, M.3
  • 38
    • 0037182013 scopus 로고    scopus 로고
    • Nonsteroidal anti-inflammatory drug use and acute myocardial infarction
    • Solomon DH, Glynn RJ, Levin R, et al. Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med 162:1099-1105.
    • Arch Intern Med , vol.162 , pp. 1099-1105
    • Solomon, D.H.1    Glynn, R.J.2    Levin, R.3
  • 39
    • 0037182008 scopus 로고    scopus 로고
    • Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis
    • Watson DJ, Rhodes T, Cai B, et al. Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis. Arch Intern Med 162:1105-1110.
    • Arch Intern Med , vol.162 , pp. 1105-1110
    • Watson, D.J.1    Rhodes, T.2    Cai, B.3
  • 40
    • 0037182023 scopus 로고    scopus 로고
    • Association between naproxen use and protection against acute myocardial infarction
    • Rahme E, Pilote L, LeLorier J. Association between naproxen use and protection against acute myocardial infarction. Arch Intern Med 162:1111-1116.
    • Arch Intern Med , vol.162 , pp. 1111-1116
    • Rahme, E.1    Pilote, L.2    LeLorier, J.3
  • 41
    • 0037182025 scopus 로고    scopus 로고
    • Selective COX-2 inhibitors, NSAIDs, aspirin and myocardial infarction
    • Dalen JE. Selective COX-2 inhibitors, NSAIDs, aspirin and myocardial infarction. Arch Intern Med 162:1091-1092.
    • Arch Intern Med , vol.162 , pp. 1091-1092
    • Dalen, J.E.1
  • 42
    • 0023805341 scopus 로고
    • Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction
    • ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988;8607:349-360.
    • (1988) Lancet , vol.8607 , pp. 349-360
  • 43
    • 0028120906 scopus 로고
    • I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
    • I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ. 308:1994;81-106.
    • (1994) BMJ , vol.308 , pp. 81-106
  • 44
    • 0035818601 scopus 로고    scopus 로고
    • Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib
    • Konstam M.A., Weir M.R., Reicin A.et al. Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. Circulation. 104:2001;15-23.
    • (2001) Circulation , vol.104 , pp. 15-23
    • Konstam, M.A.1    Weir, M.R.2    Reicin, A.3
  • 45
    • 0033524421 scopus 로고    scopus 로고
    • Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
    • McAdam BF, Catella-Lawson F, Mardini IA, et al. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA. 96:272-277.
    • Proc Natl Acad Sci USA , vol.96 , pp. 272-277
    • McAdam, B.F.1    Catella-Lawson, F.2    Mardini, I.A.3
  • 46
    • 0030816051 scopus 로고    scopus 로고
    • Altered pain perception and inflammatory responses in mice lacking prostacyclin receptor
    • Murata T., Ushikubi F., Matsuoka T.et al. Altered pain perception and inflammatory responses in mice lacking prostacyclin receptor. Nature. 388(6643):1997;678-682.
    • (1997) Nature , vol.388 , Issue.6643 , pp. 678-682
    • Murata, T.1    Ushikubi, F.2    Matsuoka, T.3
  • 47
    • 0023137593 scopus 로고
    • Inhibition of thromboxane formation in vivo and ex vivo: Implications for therapy with platelet inhibitory drugs
    • Reilly I.A., FitzGerald G.A. Inhibition of thromboxane formation in vivo and ex vivo. implications for therapy with platelet inhibitory drugs Blood. 69:1987;180-186.
    • (1987) Blood , vol.69 , pp. 180-186
    • Reilly, I.A.1    FitzGerald, G.A.2
  • 48
    • 0032931328 scopus 로고    scopus 로고
    • Epidemiology of NSAID-induced gastrointestinal complications
    • Singh G., Triadafilopoulos G. Epidemiology of NSAID-induced gastrointestinal complications. J Rheumatol. 26(Suppl 56):1999;18-24.
    • (1999) J Rheumatol , vol.26 , Issue.SUPPL. 56 , pp. 18-24
    • Singh, G.1    Triadafilopoulos, G.2
  • 49
    • 0034638656 scopus 로고    scopus 로고
    • Risk of gastrointestinal hemorrhage with long-term use of aspirin: Meta-analysis
    • Derry S., Loke Y.K. Risk of gastrointestinal hemorrhage with long-term use of aspirin. meta-analysis BMJ. 321:2000;1183-1187.
    • (2000) BMJ , vol.321 , pp. 1183-1187
    • Derry, S.1    Loke, Y.K.2
  • 50
    • 0000039129 scopus 로고    scopus 로고
    • COX-2 specific inhibitors - Is there any benefit of using these agents in patients on low dose aspirin (ASA)?
    • Singh G., Goldstein J., Agrawal N.et al. COX-2 specific inhibitors - is there any benefit of using these agents in patients on low dose aspirin (ASA)? Ann Rheum Dis. 60(Suppl. 1):2001;239.
    • (2001) Ann Rheum Dis , vol.60 , Issue.SUPPL. 1 , pp. 239
    • Singh, G.1    Goldstein, J.2    Agrawal, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.